Vision Improvement after Osimertinib Treatment in Paraneoplastic Optic Neuropathy Associated with Lung Adenocarcinoma
Treatments for paraneoplastic optic neuropathy (PON), a tumor-related autoimmune disease, include immunosuppression, plasma exchange, and immunoglobulin therapies, as well as treatment of the underlying disease. Herein, we describe the clinical course of an older adult patient with PON whose loss of...
Saved in:
Main Authors: | Masaomi Kubota, Nobumasa Tamura, Takaaki Hayashi, Euido Nishijima, Haruhiko Yanagisawa, Akira Kojima, Tadashi Nakano |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Case Reports in Ophthalmological Medicine |
Online Access: | http://dx.doi.org/10.1155/2021/2832021 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Paraneoplastic Mononeuritis Multiplex as a Presenting Feature of Adenocarcinoma of the Lung
by: Esra Ekiz, et al.
Published: (2013-01-01) -
Solid Predominant Histology and High Podoplanin Expression in Cancer-Associated Fibroblast Predict Primary Resistance to Osimertinib in EGFR-Mutated Lung Adenocarcinoma
by: Yuji Uehara, MD, et al.
Published: (2025-03-01) -
An UPLC-MS/MS Method for Determination of Osimertinib in Rat Plasma: Application to Investigating the Effect of Ginsenoside Rg3 on the Pharmacokinetics of Osimertinib
by: Zhenzhen Ying, et al.
Published: (2020-01-01) -
Cholestatic Jaundice as a Paraneoplastic Manifestation of Prostate Cancer
by: Tomomi Kuramoto, et al.
Published: (2013-01-01) -
Neratinib as a Potential Therapeutic for Mutant RAS and Osimertinib-Resistant Tumours
by: Paul Dent, et al.
Published: (2022-09-01)